Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

Medtronic receives FDA approval for new continuous glucose recorder

Medtronic : 29 January, 2008  (New Product)
Medtronic has received FDA approval of a new physician-use continuous glucose monitoring (CGM) system, the CGMS iPro Recorder.
Physicians send patients home with the CGMS iPro Recorder to uncover patterns and potential problems that often go undetected with today’s standard glucose measurements like finger stick meters and HbA1c tests.

The new CGMS iPro Recorder is smaller, lighter in weight and less time consuming to use than previous CGMS recorders. Physicians can now gain added clinical insights from the CGMS iPro Recorder in a matter of minutes, while improved ergonomics give patients added freedom when wearing the device. Physician services associated with CGMS iPro are reimbursed from Medicare in all 50 US states and have broad private insurance reimbursement.

Patients wear the CGMS iPro Recorder for three days, after which physicians can review the data and use the results to uncover glucose patterns and optimise patient therapy. Based on the detailed glycaemic profiles collected from the CGMS iPro Recorder, physicians can better tailor diabetes treatment programmes for each patient. The recorder may be helpful for patients who experience inconsistent high and low glucose levels, who experience hypoglycaemia unawareness and who generally desire better control, as well as for women with gestational diabetes and pregnant women with diabetes.

“Diabetes is a disease of individuals, and requires very specific and customized care for each patient,” said Thomas Blevins, MD, Texas Diabetes and Endocrinology, Austin, Texas, USA. “iPro will help me work with my patients to identify how everyday activities can affect their diabetes management. A tool like this has the ability to open a window into a patient’s diabetes in a way that A1c and fingerstick measurements cannot.”

The CGMS iPro Recorder is attached to a tiny glucose sensor inserted just under the skin. During the course of three days, the recorder automatically measures and stores glucose values during daily activities like work, sleep, eating, and exercise. After the recording period is completed, the patient returns to the physician’s office where the device is removed and downloaded. The physician can then generate and interpret detailed glucose reports to determine changes to the patient’s therapy.

“CGMS iPro is the latest step in Medtronic’s CGM technology revolution,” said Chris O’Connell, president of the Diabetes business at Medtronic. “Medtronic has 10 years of CGM experience, and we continue to expand the application of our technologies into new and novel spaces. CGMS iPro represents a major breakthrough in making CGM a more central element of physician practice.'

Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo